2m 2m 2m 2m 2m 2m 2m
Catalyst Pharma (CPRX)
NASDAQ
$31.39+$0.005 (+0.02%)
Price as of Jun 23, 2026 9:48 AM EDT- $3.8BMarket Cap
- 41.86%1-Year Change
- BiotechnologyIndustry
Catalyst Pharma (CPRX)
$31.39+$0.005 (+0.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 588.8M +19.74% | 491.7M +23.49% | 398.2M +85.90% | 214.2M +52.10% | |
Cost of Revenue | 87.3M +26.74% | 68.8M +32.48% | 52.0M +51.10% | 34.4M +57.16% | |
Gross Profit | 501.6M +18.60% | 422.9M +22.14% | 346.2M +92.56% | 179.8M +51.17% | |
Sales and Marketing Expense | 193.8M +9.01% | 177.7M +32.93% | 133.7M +129.81% | 58.2M +17.24% | |
Research and Development Expense | -12.7M +0.48% | -12.6M -86.42% | -93.2M +370.72% | -19.8M +16.85% | |
Depreciation and Amortization Expense | 37.5M +0.32% | 37.4M +14.78% | 32.6M +2,865.85% | 1.1M +471.88% | |
Total Operating Expenses | 87.3M +26.74% | 68.8M +32.48% | 52.0M +51.10% | 34.4M +57.16% | |
Operating Profit | 214.3M +9.84% | 195.1M +124.77% | 86.8M -14.75% | 101.8M +94.40% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 25.7M +21.75% | 21.1M +174.57% | 7.7M +167.23% | 2.9M +921.63% | |
Income before Taxes | 214.3M -0.90% | 216.3M +128.82% | 94.5M -9.75% | 104.7M +98.83% | |
Income Taxes | 69.2M +32.11% | 52.4M +126.72% | 23.1M +6.75% | 21.6M +64.13% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 214.3M +30.78% | 163.9M +129.50% | 71.4M -14.05% | 83.1M +110.42% | |
Net Income from Continuing Operations Applicable to Common | 214.3M -0.90% | 216.3M +128.82% | 94.5M -9.75% | 104.7M +98.83% | |
Basic EPS and Net Income | 1.75 +26.81% | 1.38 +105.97% | 0.67 -16.25% | 0.80 +110.53% | |
Diluted EPS and Net Income | 1.68 +28.24% | 1.31 +107.94% | 0.63 -16.00% | 0.75 +102.70% | |
Basic Weighted Average Shares | 122.3M +3.24% | 118.5M +11.46% | 106.3M +2.81% | 103.4M -0.005% | |
Diluted Weighted Average Shares | 127.3M +1.85% | 124.9M +9.84% | 113.8M +2.13% | 111.4M +3.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 709.2M +37.02% | 517.6M +276.03% | 137.6M -53.87% | 298.4M +74.05% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 709.2M +37.02% | 517.6M +276.03% | 137.6M -53.87% | 298.4M +56.01% | |
Total Current Assets | 894.0M +43.36% | 623.6M +184.33% | 219.3M -31.63% | 320.8M +52.68% | |
Accumulated Depreciation | 1.5M +33.48% | 1.1M +54.91% | 723,000 +78.08% | 406,000 +47.64% | |
Property and Plant and Equipment and Net | 1.0M -23.41% | 1.4M +13.31% | 1.2M +41.09% | 847,000 -11.68% | |
Total Long-Term Assets | 1.0M -23.41% | 1.4M +13.31% | 1.2M +41.09% | 847,000 -11.68% | |
Total Assets | 1.1B +29.66% | 851.4M +81.11% | 470.1M +25.15% | 375.6M +57.97% | |
Income Taxes Payable | 139.9M +29.45% | 108.1M +58.55% | 68.2M -14.72% | 79.9M +182.78% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 147.2M +21.94% | 120.7M +58.66% | 76.1M +32.08% | 57.6M +112.79% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 209,000 -33.65% | 315,000 -89.44% | 3.0M -78.80% | 14.1M +261.17% | |
Total Liabilities | 149.7M +20.95% | 123.8M +50.52% | 82.2M +9.34% | 75.2M +142.95% | |
Retained Earnings | 474.2M +66.29% | 285.2M +135.14% | 121.3M +143.22% | 49.9M +289.52% | |
Total Stockholders Equity | 954.3M +31.15% | 727.6M +87.59% | 387.9M +29.11% | 300.4M +45.25% | |
Total Shares Outstanding | 122.5M +1.35% | 120.9M +12.84% | 107.1M +1.77% | 105.3M +2.20% | |
Cash Flow | |||||
Cash from Operating Activities | 208.7M -12.98% | 239.8M +67.00% | 143.6M +23.74% | 116.0M +92.22% | |
Capital Expenditures | 58,000 -89.57% | 556,000 +140.69% | 231,000 +696.55% | 29,000 -97.16% | |
Cash from Investing Activities | -58,000 -89.57% | -556,000 -99.81% | -293.5M -3,287.12% | 9.2M +183.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -17.0M -112.08% | 140.7M +1,395.62% | -10.9M -740.91% | 1.7M +120.80% | |
Financials Ratio | |||||
Gross Margin | 85.18% -0.95% | 86.00% -1.09% | 86.95% +3.58% | 83.94% -0.61% | |
Operating Margin | 36.40% -8.27% | 39.68% +82.01% | 21.80% -54.14% | 47.54% +27.82% | |
Return on Assets | 21.92% -11.62% | 24.80% +46.88% | 16.89% -37.66% | 27.09% +47.55% | |
Return on Equity | 25.49% -13.26% | 29.38% +41.61% | 20.75% -36.66% | 32.76% +56.15% | |
Revenue Growth | 19.74% -15.95% | 23.49% -72.66% | 85.90% +64.88% | 52.10% +185.08% | |
Current Ratio | 6.08 +17.57% | 5.17 +79.21% | 2.88 -48.24% | 5.57 -28.25% | |
Cash Ratio | 4.82 +12.37% | 4.29 +137.01% | 1.81 -65.08% | 5.18 -18.21% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow